Počet záznamů: 1
Postremission therapy for AML with intermediate risk cytogenetics in first complete remission
- 1.VYDRA, J.; SALEK, C.; SCHWARZ, J.; CETKOVSKY, P.; ZAK, P.; NOVAK, J.; PETECUKOVA, V.; MAYER, J.; RACIL, Z. Postremission therapy for AML with intermediate risk cytogenetics in first complete remission. Haematologica. 2017, vol. 102, no. S2, s. 384. ISSN 0390-6078.
Rok vydání Rok metriky IF JCR Q (best) SJR SJR Q (best) CiteScore AIS 1. decil 2017 2017 9.090 Q1 3.063 Q1 10.3 2.675
Počet záznamů: 1